AIC
APEN

Ameritas Investment Company’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ameritas Investment Company’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed – – 1885
2018
Q4 		$0 Buy
+6
New +$30 ﹤0.01% 1594

Other funds holding APEN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NSEDCP
NJ State Employees Deferred Compensation Plan Trenton, New Jersey $906M AUM 24.85% 1-Year Est. Return

Ameritas Investment Company's APEN Position: Q1 2019 in Review

Ameritas Investment Company sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2019, closing a stake of 6 shares.

Ameritas Investment Company first reported a position in APEN in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 31 funds tracked by Wall St. Rank hold APEN as of Q1 2019.

  • Ameritas Investment Company reported no remaining Apollo Endosurgery, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 6 Apollo Endosurgery, Inc. shares in Q1 2019.
  • Ameritas Investment Company first reported a position in Apollo Endosurgery, Inc. in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Apollo Endosurgery, Inc. position peaked at $0 in Q4 2018.
  • 31 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.